These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2601986)

  • 1. The effect of verapamil on the treatment of detrusor hyperreflexia in the spinal cord injured population.
    Bodner DR; Lindan R; Leffler E; Resnick MI
    Paraplegia; 1989 Oct; 27(5):364-9. PubMed ID: 2601986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.
    Gacci M; Del Popolo G; Macchiarella A; Celso M; Vittori G; Lapini A; Serni S; Sandner P; Maggi M; Carini M
    J Urol; 2007 Nov; 178(5):2040-3; discussion 2044. PubMed ID: 17869296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study.
    El-Bahnasawy MS; Shaaban H; Gomha MA; Nabeeh A
    Scand J Urol Nephrol; 2008; 42(4):344-51. PubMed ID: 19230167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride.
    Madersbacher H; Jilg G
    Paraplegia; 1991 Feb; 29(2):84-90. PubMed ID: 2023781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
    de Sèze M; Wiart L; de Sèze MP; Soyeur L; Dosque JP; Blajezewski S; Moore N; Brochet B; Mazaux JM; Barat M; Joseph PA
    J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
    Abdel-Gawad M; Dion SB; Elhilali MM
    J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
    Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
    BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravesical instillation of varying doses of verapamil (20 mg, 40 mg, 80 mg) upon urinary bladder function in chronic traumatic paraplegics with overactive detrusor function.
    Babu R; Vaidyanathan S; Sankaranarayan A; Indudhara R
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):350-4. PubMed ID: 2272717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats.
    Abdel-Karim AM; Bialecki RA; Elhilali MM
    J Urol; 2002 Aug; 168(2):837-42. PubMed ID: 12131377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens.
    Di Stasi SM; Giannantoni A; Vespasiani G; Navarra P; Capelli G; Massoud R; Stephen RL
    J Urol; 2001 Feb; 165(2):491-8. PubMed ID: 11176403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
    Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
    BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Instability of the detrusor. Treatment with oxybutynin chloride (Ditropan) in children].
    Vallejo Herrador J; Rodríguez Luna JM; Fernández Fernández A; Perales Cabanas L; Romero Maroto J; Pérez Bustamante I
    Actas Urol Esp; 1990; 14(1):23-7. PubMed ID: 2339646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effects of intrarectal administration of oxybutynin].
    Radziszewski P; Borkowski A
    Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA; Quiroga Avila RG; Lorenzo Monterrubio JL; Moreno Aranda J
    Ginecol Obstet Mex; 2000 Apr; 68():174-81. PubMed ID: 10824450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of botulinum-A toxin on bladder function and histology in spinal cord injured rats: is there any difference between early and late application?
    Temeltas G; Tikiz C; Dagci T; Tuglu I; Yavasoglu A
    J Urol; 2005 Dec; 174(6):2393-6. PubMed ID: 16280854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A crossover randomized trial of transcutaneous electrical nerve stimulation and oxybutynin in patients with detrusor instability.
    Soomro NA; Khadra MH; Robson W; Neal DE
    J Urol; 2001 Jul; 166(1):146-9. PubMed ID: 11435843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.